ES540901A0 - Un procedimiento para la preparacion de derivados de n,n-pipericinilo disustituidos. - Google Patents

Un procedimiento para la preparacion de derivados de n,n-pipericinilo disustituidos.

Info

Publication number
ES540901A0
ES540901A0 ES540901A ES540901A ES540901A0 ES 540901 A0 ES540901 A0 ES 540901A0 ES 540901 A ES540901 A ES 540901A ES 540901 A ES540901 A ES 540901A ES 540901 A0 ES540901 A0 ES 540901A0
Authority
ES
Spain
Prior art keywords
pipericinyl
disstituted
derivatives
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES540901A
Other languages
English (en)
Other versions
ES8607254A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES540901A0 publication Critical patent/ES540901A0/es
Publication of ES8607254A1 publication Critical patent/ES8607254A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/12—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Legs For Furniture In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES540901A 1984-03-06 1985-03-04 Un procedimiento para la preparacion de derivados de n,n-pipericinilo disustituidos. Expired ES8607254A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58658084A 1984-03-06 1984-03-06
US06/683,309 US4605655A (en) 1984-03-06 1984-12-18 Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives

Publications (2)

Publication Number Publication Date
ES540901A0 true ES540901A0 (es) 1986-05-16
ES8607254A1 ES8607254A1 (es) 1986-05-16

Family

ID=27079753

Family Applications (1)

Application Number Title Priority Date Filing Date
ES540901A Expired ES8607254A1 (es) 1984-03-06 1985-03-04 Un procedimiento para la preparacion de derivados de n,n-pipericinilo disustituidos.

Country Status (27)

Country Link
US (1) US4605655A (es)
KR (3) KR920005113B1 (es)
AT (1) AT390951B (es)
AU (1) AU576555B2 (es)
BE (1) BE901880A (es)
CA (1) CA1256871A (es)
CH (1) CH663022A5 (es)
CY (1) CY1545A (es)
DE (1) DE3507983A1 (es)
DK (1) DK166149C (es)
ES (1) ES8607254A1 (es)
FI (1) FI84478C (es)
FR (1) FR2560878B1 (es)
GB (1) GB2155925B (es)
GR (1) GR850561B (es)
HK (1) HK82890A (es)
HU (1) HU193949B (es)
IE (1) IE58338B1 (es)
IT (1) IT1183483B (es)
LU (1) LU85796A1 (es)
MX (1) MX9203177A (es)
MY (1) MY102240A (es)
NL (1) NL8500628A (es)
PT (1) PT80058B (es)
SE (1) SE462429B (es)
SG (1) SG35590G (es)
ZA (1) ZA851486B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668687A (en) * 1984-07-23 1987-05-26 Bristol-Myers Company Psychogeriatric 1-(2-pyrimidinyl)piperazinyl derivatives of 1-pyrrolidin-2-ones
US4677104A (en) * 1985-05-06 1987-06-30 Bristol-Myers Company Antipsychotic fused-ring pyridinylpiperazine derivatives
US4766215A (en) * 1987-02-27 1988-08-23 American Home Products Corporation Histamine H1 -receptor antagonists
SE8701375D0 (sv) * 1987-04-02 1987-04-02 Leo Ab Novel pyridyl- and pyrimidyl derivatives
US4826844A (en) * 1987-09-30 1989-05-02 American Home Products Corporation Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols
MX173180B (es) * 1987-10-26 1994-02-07 Pfizer Procedimiento para preparar agentes ansioliticos
US4882432A (en) * 1989-01-09 1989-11-21 American Home Products Corporation Polycyclic-carbamic acid piperazinoalkyl esters and amides
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
EP0395313B1 (en) * 1989-04-22 1999-12-15 American Home Products Corporation Tertiary alkyl functionalized piperazine derivatives
US4994460A (en) * 1989-06-01 1991-02-19 Bristol-Myers Squibb Co. Agents for treatment of brain ischemia
US5055470A (en) * 1989-06-01 1991-10-08 Bristol-Myers Squibb Co. Method of treatment of ischemia in brain
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
US5656762A (en) * 1990-12-28 1997-08-12 Neurogen Corporation 4-piperidino-and piperazinomethyl-2-phenylimidazole derivatives, dopamine receptor subtype specific ligands
US5681956A (en) * 1990-12-28 1997-10-28 Neurogen Corporation 4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands
US5512584A (en) * 1991-04-16 1996-04-30 Basf Aktiengesellschaft 1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof
EP0538693A3 (en) * 1991-10-23 1994-08-17 Squibb & Sons Inc Stereoselective preparation of halophenyl alcohols
IL103499A0 (en) * 1991-10-24 1993-03-15 Bristol Myers Squibb Co Pharmaceutical compositions for treating anxiety in benzodiazepine withdrawn patients
SE9201239D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Agents for treating substance abuse disorders
US5324662A (en) * 1992-05-15 1994-06-28 E. R. Squibb & Sons, Inc. Stereoselective microbial or enzymatic reduction of 3,5-dioxo esters to 3-hydroxy-5-oxo, 3-oxo-5-hydroxy, and 3,5-dihydroxy esters
DE4243287A1 (de) * 1992-06-19 1993-12-23 Basf Ag N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
DE4219973A1 (de) * 1992-06-19 1993-12-23 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
RU2124511C1 (ru) * 1993-05-14 1999-01-10 Фармасьютикал Ко., Лтд Производные пиперазина
ES2074946B1 (es) * 1993-07-19 1996-06-16 Ferrer Int Nuevos compuestos derivados de la 1,2-etanodiamina-n,n,n',n'-tetrasustituida.
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
CA2187542C (en) * 1994-04-18 2000-02-01 Nobuyuki Takahashi Adamantane derivative, process for producing the same, and use thereof
US5607936A (en) * 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists
ES2104509B1 (es) * 1995-06-13 1998-07-01 Ferrer Int Nuevos compuestos derivados de 2-(3,4-disustituido-1-piperazinil)-5-fluoropirimidina.
US6166205A (en) * 1998-09-02 2000-12-26 Neurogen Corporation 2-Aryl-4-(1-[4-heteroaryl]piperazin-1-yl)methylimidazoles: dopamine . D.sub4 receptor subtype ligands
BRPI0811245B1 (pt) 2007-05-14 2021-05-25 Sk Biopharmaceuticals Co., Ltd Composto derivado de carbamoilóxi-aril-alcanoil-aril-piperazinas e seus usos
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
JP2023526515A (ja) 2020-05-20 2023-06-21 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ リソソーム蓄積症をヒスタチンペプチドで処置するための方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE589092A (es) * 1959-03-26
US2973360A (en) * 1959-10-12 1961-02-28 Paul A J Janssen Certain 1-(2-theonyl lower alkyl)-4-(heterocyclic substituted)-piperazines
US2979508A (en) * 1959-10-12 1961-04-11 Paul A J Janssen Heterocyclic derivatives of 1-phenyl-omega-(piperazine) alkanols
US2985657A (en) * 1959-10-12 1961-05-23 Paul A J Janssen 1-(aroylalkyl)-4-heterocyclylpiperazines
NL127996C (es) * 1963-11-19
GB1259685A (en) * 1969-04-03 1972-01-12 Soc D Etudes Prod Chimique Amino-pyrimidine derivatives
BE758380A (fr) * 1969-11-04 1971-04-16 Sumitomo Chemical Co Procede de preparation de derives d'aryl-cetones
GB1307256A (en) * 1970-09-15 1973-02-14 Science Union & Cie Piperazine derivatives and a process for their preparation
BE882836A (fr) * 1979-05-15 1980-08-18 Soc D Etudes Prod Chimique Nouveaux derives halogenes de l'isopropylamino pyrimidine, leur preparation et leur utilisaton therapeutique
US4316899A (en) * 1979-08-24 1982-02-23 Beecham Group Limited Chromanone derivatives, a process for their preparation and compositions containing them
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
IT8519773A0 (it) 1985-03-05
CA1256871A (en) 1989-07-04
DK100685A (da) 1985-09-07
KR850006402A (ko) 1985-10-05
ES8607254A1 (es) 1986-05-16
GB8505662D0 (en) 1985-04-03
SG35590G (en) 1990-07-13
SE462429B (sv) 1990-06-25
MX9203177A (es) 1992-07-01
US4605655A (en) 1986-08-12
ATA64985A (de) 1990-01-15
ZA851486B (en) 1985-11-27
KR920005694B1 (ko) 1992-07-13
AU3944985A (en) 1985-09-12
NL8500628A (nl) 1985-10-01
FR2560878A1 (fr) 1985-09-13
AT390951B (de) 1990-07-25
CH663022A5 (de) 1987-11-13
IE58338B1 (en) 1993-09-08
GB2155925A (en) 1985-10-02
GB2155925B (en) 1987-11-25
HUT37781A (en) 1986-02-28
LU85796A1 (fr) 1985-12-12
DK166149C (da) 1993-08-09
HU193949B (en) 1987-12-28
FR2560878B1 (fr) 1988-10-14
FI84478B (fi) 1991-08-30
AU576555B2 (en) 1988-09-01
PT80058B (pt) 1987-10-20
DK166149B (da) 1993-03-15
DE3507983A1 (de) 1985-09-12
FI850850A0 (fi) 1985-03-01
PT80058A (en) 1985-04-01
HK82890A (en) 1990-10-19
MY102240A (en) 1992-05-15
CY1545A (en) 1991-03-22
SE8501067L (sv) 1985-09-07
IT1183483B (it) 1987-10-22
DK100685D0 (da) 1985-03-05
SE8501067D0 (sv) 1985-03-05
FI850850L (fi) 1985-09-07
GR850561B (es) 1985-07-03
BE901880A (fr) 1985-09-05
FI84478C (fi) 1991-12-10
IE850546L (en) 1985-09-06
KR920005114B1 (ko) 1992-06-26
KR920005113B1 (ko) 1992-06-26

Similar Documents

Publication Publication Date Title
ES540901A0 (es) Un procedimiento para la preparacion de derivados de n,n-pipericinilo disustituidos.
ES544644A0 (es) Un procedimiento para la preparacion de derivados de carboxamidoadenosina.
ES556550A0 (es) Un procedimiento para la preparacion de androsta -1-4-dien-3,17-dionas.
ES538256A0 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
ES546347A0 (es) Un procedimiento para la preparacion de derivados de piperazina 1,4-disustituidos.
ES545464A0 (es) Un procedimiento para la preparacion de tetrahidroftalimidas.
ES540705A0 (es) Un procedimiento para la preparacion de 17b-carbamoil-n-monosustituido -o 17b-acil-4-aza-5-alfa-androstien-3-onas.
ES539852A0 (es) Un nuevo procedimiento para la preparacion de nuevos derivados. de carbazolona.
ES546236A0 (es) Un procedimiento para la preparacion de derivados de bencimidasol.
ES541200A0 (es) Un procedimiento para la preparacion de un derivado de dibenzoilmetano.
ES542703A0 (es) Un procedimiento para la preparacion de derivados de tiazol,2, 4, disustituidos.
ES540609A0 (es) Un procedimiento para la preparacion de pirazolo piridinas.
ES546872A0 (es) Un procedimiento para la preparacion de aminoalcoxibenzopiranonas.
ES540610A0 (es) Un procedimiento para la preparacion de pirazolopiridinas.
ES544521A0 (es) Un procedimiento para la preparacion de triazolobenzodiazefinas.
ES550504A0 (es) Un procedimiento para la preparacion de derivados de podofilotoxina.
ES541781A0 (es) Un procedimiento para la preparacion de nuevos benzotiopenos.
ES545162A0 (es) Un procedimiento para la preparacion de derivados de aminofenol.
ES547805A0 (es) Un procedimiento para la preparacion de nuevos derivados de guanina.
ES547205A0 (es) Un procedimiento para la preparacion de nuevas quinazolindionas.
ES543997A0 (es) Un procedimiento para la preparacion de derivados de 1,4-dihidropiridina.
ES544221A0 (es) Un procedimiento para la preparacion de derivados de etanolamina.
ES550874A0 (es) Un procedimiento para la preparacion de 3,4-dihidroxifemetilamino derivados 2-ustituidos.
ES528225A0 (es) Un procedimiento para la preparacion de nuevos derivados de 1,2,5,-tidiazol.
ES535551A0 (es) Un procedimiento para la preparacion de nuevos 16-fluor-16,17-dideshidro prostanoides.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20051231